Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiro Maekawa

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Biological & Pharmaceutical Bulletin|February 5, 2002
Characterization of human lactoferricin as a potent protein kinase CK2 activator regulated by A-kinase in vitroToshiro Maekawa, Michio Fujihara, Kenzo Ohtsuki
Materials Science & Engineering. C, Materials for Biological Applications|December 11, 2014
A novel effect of parylene-based surface coating on HepG2 cell functionHideto Tozawa, Toshiro Maekawa, Hiroshi Kimura, et al.
Journal of Hepatology|December 7, 2010
A single nucleotide polymorphism in activated Cdc42 associated tyrosine kinase 1 influences the interferon therapy in hepatitis C patientsYoshifumi Fujimoto, Hidenori Ochi, Toshiro Maekawa, et al.
Biotechnology Progress|May 28, 2019
Investigation of the hepatic respiration and liver zonation on rat hepatocytes using an integrated oxygen biosensor in a microscale deviceSatomi Matsumoto, Astia R Safitri, Mathieu Danoy, et al.
The Journal of General Virology|October 5, 2012
Single-nucleotide polymorphisms in GALNT8 are associated with the response to interferon therapy for chronic hepatitis CRikita Nakano, Toshiro Maekawa, Hiromi Abe, et al.
Gastroenterology|February 12, 2009
A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis CHironobu Tsukada, Hidenori Ochi, Toshiro Maekawa, et al.
Gastroenterology|July 20, 2010
ITPA polymorphism affects ribavirin-induced anemia and outcomes of therapy--a genome-wide study of Japanese HCV virus patientsHidenori Ochi, Toshiro Maekawa, Hiromi Abe, et al.
Journal of Hepatology|December 15, 2010
IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapyHiromi Abe, C Nelson Hayes, Hidenori Ochi, et al.
Journal of Medical Virology|October 16, 2007
Successful treatment of an entecavir-resistant hepatitis B virus variantHiromi Yatsuji, Nobuhiko Hiraga, Nami Mori, et al.
The Journal of General Virology|January 26, 2007
Dual effect of APOBEC3G on Hepatitis B virusChiemi Noguchi, Nobuhiko Hiraga, Nami Mori, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Biological & Pharmaceutical Bulletin|February 5, 2002
Characterization of human lactoferricin as a potent protein kinase CK2 activator regulated by A-kinase in vitroToshiro Maekawa, Michio Fujihara, Kenzo Ohtsuki
Materials Science & Engineering. C, Materials for Biological Applications|December 11, 2014
A novel effect of parylene-based surface coating on HepG2 cell functionHideto Tozawa, Toshiro Maekawa, Hiroshi Kimura, et al.
Journal of Hepatology|December 7, 2010
A single nucleotide polymorphism in activated Cdc42 associated tyrosine kinase 1 influences the interferon therapy in hepatitis C patientsYoshifumi Fujimoto, Hidenori Ochi, Toshiro Maekawa, et al.
Biotechnology Progress|May 28, 2019
Investigation of the hepatic respiration and liver zonation on rat hepatocytes using an integrated oxygen biosensor in a microscale deviceSatomi Matsumoto, Astia R Safitri, Mathieu Danoy, et al.
The Journal of General Virology|October 5, 2012
Single-nucleotide polymorphisms in GALNT8 are associated with the response to interferon therapy for chronic hepatitis CRikita Nakano, Toshiro Maekawa, Hiromi Abe, et al.
Gastroenterology|February 12, 2009
A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis CHironobu Tsukada, Hidenori Ochi, Toshiro Maekawa, et al.
Gastroenterology|July 20, 2010
ITPA polymorphism affects ribavirin-induced anemia and outcomes of therapy--a genome-wide study of Japanese HCV virus patientsHidenori Ochi, Toshiro Maekawa, Hiromi Abe, et al.
Journal of Hepatology|December 15, 2010
IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapyHiromi Abe, C Nelson Hayes, Hidenori Ochi, et al.
Journal of Medical Virology|October 16, 2007
Successful treatment of an entecavir-resistant hepatitis B virus variantHiromi Yatsuji, Nobuhiko Hiraga, Nami Mori, et al.
The Journal of General Virology|January 26, 2007
Dual effect of APOBEC3G on Hepatitis B virusChiemi Noguchi, Nobuhiko Hiraga, Nami Mori, et al.
Pageof 3